Yang Qingling, Cheung Kin, Zhang Yan, Zhang Yazhou, Qin Jing, Xie Yao Jie
School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Int J Nurs Stud. 2025 Mar;163:104991. doi: 10.1016/j.ijnurstu.2024.104991. Epub 2024 Dec 28.
Effective management of physical and psychological symptoms is a critical component of comprehensive care for both chronic disease patients and apparently healthy individuals experiencing episodic symptoms. Conversational agents, which are dialog systems capable of understanding and generating human language, have emerged as a potential tool to enhance symptom management through interactive support.
To examine the characteristics and effectiveness of conversational agent-delivered interventions reported in randomized controlled trials (RCTs) in the management of both physical and psychological symptoms.
A systematic review.
A comprehensive search was performed in Pubmed, ACM Digital Library, CINAHL, EMBASE, PyscInfo, Web of Science, Scopus and gray literature sources from their inception to Oct 2024. Search terms included "conversational agent", "symptom", "randomized controlled trial" and their synonyms and hyponyms. Duplicates were identified by EndNote, and titles, abstracts and full texts were independently screened according to predefined criteria. Data extraction focused on basic study characteristics and conversational agent details, with The Cochrane Risk of Bias 2.0 tool employed for bias assessment.
The search yielded 2756 articles and 29 were finally included for review. The included studies predominantly came from developed countries (n = 23) and were conducted between 2020 and 2024 (n = 24). The studies frequently evaluated the feasibility and acceptability of conversational agent interventions (n = 14), with a predominantly focus on psychological symptoms (depression, anxiety, etc.) (n = 17). A few studies focused on physical symptoms (pain, etc.) (n = 4), while others addressed both symptoms (n = 8). Twenty-five distinct conversational agents (Woebot, Tess, etc.) were evaluated, utilizing platforms ranging from proprietary applications to common messaging channels like WeChat and Facebook Messenger. Cognitive Behavioral Therapy (CBT) was a commonly integrated approach (n = 22), with rule-based dialogs (n = 22) as the most commonly dialog system methods and Natural Language Processing (NLP) (n = 15) as the predominant AI techniques. The median recruitment and completion rates were 72 % and 79 %, respectively. The majority of studies reported positive user experiences and significant symptom management improvements (n = 22). However, risk of bias was high in seventeen studies and presented some concerns in nine others.
Conversational agents have shown promise in enhancing both physical and psychological symptom management through positive user experiences and effectiveness. However, the high risk of bias identified in many studies warrants caution in interpreting these findings. Future research should prioritize the methodological quality of RCTs to strengthen the evidence base supporting the use of conversational agents as a complementary tool in symptom management.
有效管理身体和心理症状是慢性病患者及有间歇性症状的看似健康个体综合护理的关键组成部分。对话代理作为一种能够理解和生成人类语言的对话系统,已成为通过交互式支持加强症状管理的潜在工具。
研究随机对照试验(RCT)中报告的对话代理干预措施在身体和心理症状管理方面的特征和有效性。
系统评价。
从创刊至2024年10月,在PubMed、ACM数字图书馆、CINAHL、EMBASE、PsycInfo、科学网、Scopus和灰色文献来源中进行全面检索。检索词包括“对话代理”“症状”“随机对照试验”及其同义词和下位词。通过EndNote识别重复项,并根据预定义标准独立筛选标题、摘要和全文。数据提取侧重于基础研究特征和对话代理细节,采用Cochrane偏倚风险2.0工具进行偏倚评估。
检索得到2756篇文章,最终纳入29篇进行综述。纳入研究主要来自发达国家(n = 23),开展时间为2020年至2024年(n = 24)。这些研究经常评估对话代理干预措施的可行性和可接受性(n = 14),主要关注心理症状(抑郁、焦虑等)(n = 17)。少数研究关注身体症状(疼痛等)(n = 4),其他一些研究则同时涉及两种症状(n = 8)。评估了25种不同的对话代理(Woebot、Tess等),使用的平台从专有应用程序到微信和Facebook Messenger等常见消息渠道不等。认知行为疗法(CBT)是一种常用的综合方法(n = 22),基于规则的对话(n = 22)是最常用的对话系统方法,自然语言处理(NLP)(n = 15)是主要的人工智能技术。招募率和完成率中位数分别为72%和79%。大多数研究报告了积极的用户体验和症状管理的显著改善(n = 22)。然而,17项研究的偏倚风险较高,另有9项研究存在一些问题。
对话代理通过积极的用户体验和有效性,在加强身体和心理症状管理方面显示出前景。然而,许多研究中发现的高偏倚风险值得在解释这些结果时谨慎对待。未来研究应优先考虑随机对照试验的方法学质量,以加强支持将对话代理作为症状管理补充工具的证据基础。